This federal contract award to Immucor Inc., a for-profit manufacturer, is for the provision of reagents and an echo analyzer to support blood bank operations. The $784,855.51 firm fixed price purchase order was awarded on October 1, 2016 by the Medical Command division of the Department of Defense, with a period of performance through September 30, 2019. No set-aside designation was used. Immucor has previously provided a variety of in vitro diagnostic products, reagents, test kits, and blood banking supplies to federal agencies under direct contracts and multiple award schedule vehicles. This award facilitates the recurring procurement of essential blood analysis equipment and consumables to enable critical transfusion and transplantation medicine services within the military healthcare network.